Genmab reported 1.42B in Operating Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Agios Pharmaceuticals AGIO:US $ 89.16M 66K
Alexion Pharmaceuticals ALXN:US $ 1000.3M 30.6M
Amarin AMRN:US 155.11M 9.4M
Amgen AMGN:US $ 4.33B 1.37B
AstraZeneca AZN:LN 11.54B 4.45B
Bayer BAYN:GR 9.25B 3.88B
Biomarin Pharmaceutical BMRN:US $ 461.96M 28.06M
Bluebird Bio BLUE:US $ 239.63M 8.68M
Exelixis EXEL:US $ 276.8M 14.63M
Fresenius Medical Care FME:GR 3.94B 40.05M
Galapagos GLPG:NA 155.17M 44.65M
Genmab GEN:DC 1.42B 235M
GlaxoSmithKline GSK:LN 7.14B 722M
GN Store Nord GN:DC 3.22B 22M
GRIFOLS GRF:SM 1.1B 129.52M
H. Lundbeck A/S LUN:DC 3.49B 123M
Hikma Pharmaceutical HIK:LN 873M 27M
Immunogen IMGN:US $ 43.44M 873K
Insmed INSM:US $ 150.37M 1.25M
Lonza Group LONN:SW 2.22B 1.07B
Merck MRK:GR 3.93B 105M
Novartis NOVN:VX 10.13B 319M
Regeneron Pharmaceuticals REGN:US $ 1605.6M 185.7M
Seattle Genetics SGEN:US $ 722.02M 243.94M
William Demant Holding WDH:DC 7.37B 399M